Javascript must be enabled to continue!
Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.
View through Europeana Collections
BACKGROUND: Despite a decreasing incidence of peptic ulcer disease, most previous studies report a stabile incidence of ulcer complications. We wanted to investigate the incidence of peptic ulcer complications in Sweden before and after the introduction of the proton pump inhibitors (PPI) in 1988 and compare these data to the sales of non-steroid anti-inflammatory drugs (NSAID) and acetylsalicylic acid (ASA).METHODS: All cases of gastric and duodenal ulcer complications diagnosed in Sweden from 1974 to 2002 were identified using the National hospital discharge register. Information on sales of ASA/NSAID was obtained from the National prescription survey. RESULTS: When comparing the time-periods before and after 1988 we found a significantly lower incidence of peptic ulcer complications during the later period for both sexes (p < 0.001). Incidence rates varied from 1.5 to 7.8/100000 inhabitants/year regarding perforated peptic ulcers and from 5.2 to 40.2 regarding peptic ulcer bleeding. The number of sold daily dosages of prescribed NSAID/ASA tripled from 1975 to 2002. The number of prescribed sales to women was higher than to males. Sales of low-dose ASA also increased. The total volume of NSAID and ASA, i.e. over the counter sale and sold on prescription, increased by 28% during the same period.CONCLUSION: When comparing the periods before and after the introduction of the proton pump inhibitors we found a significant decrease in the incidence of peptic ulcer complications in the Swedish population after 1988 when PPI were introduced on the market. The cause of this decrease is most likely multifactorial, including smoking habits, NSAID consumption, prevalence of Helicobacter pylori and the introduction of PPI. Sales of prescribed NSAID/ASA increased, especially in middle-aged and elderly women. This fact seems to have had little effect on the incidence of peptic ulcer complications.
Uppsala University
Title: Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.
Description:
BACKGROUND: Despite a decreasing incidence of peptic ulcer disease, most previous studies report a stabile incidence of ulcer complications.
We wanted to investigate the incidence of peptic ulcer complications in Sweden before and after the introduction of the proton pump inhibitors (PPI) in 1988 and compare these data to the sales of non-steroid anti-inflammatory drugs (NSAID) and acetylsalicylic acid (ASA).
METHODS: All cases of gastric and duodenal ulcer complications diagnosed in Sweden from 1974 to 2002 were identified using the National hospital discharge register.
Information on sales of ASA/NSAID was obtained from the National prescription survey.
RESULTS: When comparing the time-periods before and after 1988 we found a significantly lower incidence of peptic ulcer complications during the later period for both sexes (p < 0.
001).
Incidence rates varied from 1.
5 to 7.
8/100000 inhabitants/year regarding perforated peptic ulcers and from 5.
2 to 40.
2 regarding peptic ulcer bleeding.
The number of sold daily dosages of prescribed NSAID/ASA tripled from 1975 to 2002.
The number of prescribed sales to women was higher than to males.
Sales of low-dose ASA also increased.
The total volume of NSAID and ASA, i.
e.
over the counter sale and sold on prescription, increased by 28% during the same period.
CONCLUSION: When comparing the periods before and after the introduction of the proton pump inhibitors we found a significant decrease in the incidence of peptic ulcer complications in the Swedish population after 1988 when PPI were introduced on the market.
The cause of this decrease is most likely multifactorial, including smoking habits, NSAID consumption, prevalence of Helicobacter pylori and the introduction of PPI.
Sales of prescribed NSAID/ASA increased, especially in middle-aged and elderly women.
This fact seems to have had little effect on the incidence of peptic ulcer complications.
Related Results
Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia
Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia
Abstract
Background
Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for ...
Evaluation of H. pylori - Eradication Triple Therapy in Iraqi Peptic Ulcer Patients according to ABO Phenotypes: a New Study
Evaluation of H. pylori - Eradication Triple Therapy in Iraqi Peptic Ulcer Patients according to ABO Phenotypes: a New Study
Infection with H. pylori is an up growing public health problem that affects approximately 50% of people in industrialized nations, and up to 80% in developing countries. Helicoba...
Anti-Saccharomyces cerevisiae antibodies (ASCA) in peptic ulcer disease with Helicobacter pylori
Anti-Saccharomyces cerevisiae antibodies (ASCA) in peptic ulcer disease with Helicobacter pylori
Anti-Saccharomyces cerevisiae antibodies (ASCA) is related to the pathogenesis of Crohn’s disease as digestive tract inflammation. But the relationship between ASCA and peptic ulce...
Diagnostic validity of peptic ulcer perforation scoring system in predicting mortality in patients with perforated peptic ulcer at a tertiary care hospital in India
Diagnostic validity of peptic ulcer perforation scoring system in predicting mortality in patients with perforated peptic ulcer at a tertiary care hospital in India
Background: One of the prevalent ailments impacting the population of India is peptic ulcer. Although generally benign in its course, it can cause dangerous complications such as p...
Factors associated with gastro-duodenal ulcer in compensated type 2 diabetic patients: a Romanian single-center study
Factors associated with gastro-duodenal ulcer in compensated type 2 diabetic patients: a Romanian single-center study
IntroductionIntroduction: Helicobacter pylori infection is accepted as the leading cause of chronic gastritis, ulcer disease and gastric cancer, with an important impact on health ...
History of Antiulcer Drugs
History of Antiulcer Drugs
Abstract
The therapy of peptic ulcer disease has progressively changed in the last two centuries. Major discoveries were achieved...
Determinants of Peptic Ulcer
Determinants of Peptic Ulcer
Globally, peptic ulcer is a disease that is very common in an adult population with 10% prevalence.Patients with H.pylori infection has 3 to 4 folds higher risk of getting peptic u...
Study on the characteristics of microcirculation in the site of pressure ulcer in patients with spinal cord injury
Study on the characteristics of microcirculation in the site of pressure ulcer in patients with spinal cord injury
To investigate the characteristics of pressure ulcer microcirculation in SCI patients with pressure ulcer, and to provide evidence for the treatment of pressure ulcer in patients w...


